Yogurt and cardiometabolic diseases: A critical review of potential mechanisms

Advances in Nutrition

Volumn 8, Issue 6, 2017, Pages 812-829

  Fernandez, Melissa Anne ^a,b   Panahi, Shirin ^b   Daniel, Noémie ^a,b   Tremblay, Angelo ^a,b   Marette, André ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Bioactive peptides; Cardiometabolic diseases; Dairy; Fermented dairy; Foodmatrix; Hypertension; Microbiota; Obesity; Type 2 diabetes; Yogurt

Indexed keywords

YOGHURT;

CARDIOVASCULAR DISEASE; DIET; EATING; HUMAN; METABOLIC SYNDROME X; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES;

CARDIOVASCULAR DISEASES; DIET; EATING; HUMANS; METABOLIC SYNDROME; YOGURT;

EID: 85034031655     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.116.013946     Document Type: Review

References (219)

1. Bohl M, Bjornshave A, Larsen MK, Gregersen S, Hermansen K. The effects of proteins and medium-chain fatty acids from milk on body composition, insulin sensitivity and blood pressure in abdominally obese adults. Eur J Clin Nutr 2017;71:76-82.
2. Gijsbers L, Ding EL, Malik VS, de Goede J, Geleijnse JM, Soedamah-Muthu SS. Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Am J Clin Nutr 2016;103:1111-24.
3. Chen M, Sun Q, Giovannucci E, Mozaffarian D, Manson JE, WillettWC, Hu FB. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med 2014;12:215.
4. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response metaanalysis of cohort studies. Am J Clin Nutr 2013;98:1066-83.
5. Kirii K, Mizoue T, Iso H, Takahashi Y, Kato M, Inoue M, Noda M, Tsugane S. Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 2009;52:2542-50.
6. Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in theWhitehall II study. Br J Nutr 2013;109:718-26.
7. Grantham NM, Magliano DJ, Hodge A, Jowett J, Meikle P, Shaw JE. The association between dairy food intake and the incidence of diabetes in Australia: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Public Health Nutr 2013;16:339-45.
8. Brouwer-Brolsma EM, Dhonukshe-Rutten RA, van Wijngaarden JP, Zwaluw NL, Velde N, de Groot LC. Dietary sources of vitamin B-12 and their association with vitamin B-12 status markers in healthy older adults in the B-PROOF study. Nutrients 2015;7:7781-97.
9. Margolis KL, Wei F, de Boer IH, Howard BV, Liu S, Manson JE, Mossavar-Rahmani Y, Phillips LS, Shikany JM, Tinker LF. A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. J Nutr 2011;141:1969-74.
10. Liu S, Choi HK, Ford E, Song Y, Klevak A, Buring JE, Manson JE. A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 2006;29:1579-84.
11. Díaz-López A, Bulló M, Martínez-González MA, Corella D, Estruch R, Fitó M, Gómez-Gracia E, Fiol M, García de la Corte FJ, Ros E, et al. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur J Nutr 2016;55:349-60.
12. O'Connor LM, Lentjes MA, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 2014;57:909-17.
13. Babio N, Becerra-Tomas N, Martinez-Gonzalez MA, Corella D, Estruch R, Ros E, Sayon-Orea C, Fito M, Serra-Majem L, Aros F, et al. Consumption of yogurt, low-fat milk, and other low-fat dairy products is associated with lower risk of metabolic syndrome incidence in an elderly Mediterranean population. J Nutr 2015;145:2308-16.
14. Pereira MA, Jacobs DR Jr., Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 2002;287: 2081-9.
15. Snijder MB, van Dam RM, Stehouwer CD, Hiddink GJ, Heine RJ, Dekker JM. A prospective study of dairy consumption in relation to changes in metabolic risk factors: the Hoorn Study. Obesity (Silver Spring) 2008;16:706-9.
16. Sayón-Orea C, Bes-Rastrollo M, Marti A, Pimenta AM, Martin-Calvo N, Martinez-Gonzalez MA. Association between yogurt consumption and the risk of metabolic syndrome over 6 years in the SUN study. BMC Public Health 2015;15:170.
17. Drouin-Chartier J-P, Brassard D, Tessier-Grenier M, Côté JA, Labonté M-E, Desroches S, Couture P, Lamarche B. Systematic review of the association between dairy product consumption and risk of cardiovascular-related clinical outcomes. Adv Nutr 2016;7:1026-40.
18. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011;364:2392-404.
19. Zemel MB, Richards J, Mathis S, Milstead A, Gebhardt L, Silva E. Dairy augmentation of total and central fat loss in obese subjects. Int J Obes (Lond) 2005;29:391-7.
20. Eales J, Lenoir-Wijnkoop I, King S, Wood H, Kok FJ, Shamir R, Prentice A, Edwards M, Glanville J, Atkinson RL. Is consuming yoghurt associated with weight management outcomes? Results from a systematic review. Int J Obes (Lond) 2016 40:731-46.
21. Sayon-Orea C, Martinez-Gonzalez MA, Ruiz-Canela M, Bes-Rastrollo M. Associations between yogurt consumption and weight gain and risk of obesity and metabolic syndrome: a systematic review. Adv Nutr 2017;8:146S-54S.
22. Avalos EE, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Bergstrom JN, Al-Delaimy WK. Is dairy product consumption associated with the incidence of CHD? Public Health Nutr 2013;16:2055-63.
23. Praagman J, Franco OH, Ikram MA, Soedamah-Muthu SS, Engberink MF, van Rooij FJ, Hofman A, Geleijnse JM. Dairy products and the risk of stroke and coronary heart disease: the Rotterdam Study. Eur J Nutr 2015;54:981-90.
24. Bonthuis M, Hughes MC, Ibiebele TI, Green AC, van der Pols JC. Dairy consumption and patterns of mortality of Australian adults. Eur J Clin Nutr 2010;64:569-77.
25. Larsson SC, Mannisto S, Virtanen MJ, Kontto J, Albanes D, Virtamo J. Dairy foods and risk of stroke. Epidemiology 2009;20:355-60.
26. Patterson E, Larsson SC, Wolk A, Akesson A. Association between dairy food consumption and risk of myocardial infarction in women differs by type of dairy food. J Nutr 2013;143:74-9.
27. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, WillettWC, Geleijnse JM. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response metaanalysis of prospective cohort studies. Am J Clin Nutr 2011;93:158-71.
28. Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr 2010;103:1778-83.
29. Alexander DD, Bylsma LC, Vargas AJ, Cohen SS, Doucette A, MohamedM, Irvin SR, Miller PE, WatsonH, Fryzek JP. Dairy consumption and CVD: a systematic review and meta-analysis. Br J Nutr 2016;115:737-50.
30. Guo J, Astrup A, Lovegrove JA, Gijsbers L, Givens DI, Soedamah-Muthu SS. Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol 2017;32:269-87.
31. Wu L, Sun D. Consumption of yogurt and the incident risk of cardiovascular disease: a meta-analysis of nine cohort studies. Nutrients 2017;9:315.
32. Panahi S, Fernandez MA, Marette A, Tremblay A. Yogurt, diet quality and lifestyle factors. Eur J Clin Nutr 2017;71:573-9.
33. Tremblay A, Panahi S. Yogurt consumption as a signature of a healthy diet and lifestyle. J Nutr 2017;147:1476S-80S.
34. Zhu Y, Wang H, Hollis JH, Jacques PF. The associations between yogurt consumption, diet quality, and metabolic profiles in children in the USA. Eur J Nutr 2015;54:543-50.
35. Martinez-Gonzalez MA, Sayon-Orea C, Ruiz-Canela M, de la Fuente C, Gea A, Bes-Rastrollo M. Yogurt consumption, weight change and risk of overweight/obesity: the SUN cohort study. Nutr Metab Cardiovasc Dis 2014;24:1189-96.
36. Jacques PF, Wang H. Yogurt and weight management. Am J Clin Nutr 2014;99:1229S-34S.
37. van Meijl LE, Mensink RP. Low-fat dairy consumption reduces systolic blood pressure, but does not improve other metabolic risk parameters in overweight and obese subjects. Nutr Metab Cardiovasc Dis 2011;21:355-61.
38. Azadbakht L, Haghighatdoost F, Karimi G, Esmaillzadeh A. Effect of consuming salad and yogurt as preload on body weight management and cardiovascular risk factors: a randomized clinical trial. Int J Food Sci Nutr 2013;64:392-9.
39. Shlisky JD, Durward CM, Zack MK, Gugger CK, Campbell JK, Nickols-Richardson SM. An energy-reduced dietary pattern, including moderate protein and increased nonfat dairy intake combined with walking promotes beneficial body composition and metabolic changes in women with excess adiposity: a randomized comparative trial. Food Sci Nutr 2015;3:376-93.
40. Veiga P, Pons N, Agrawal A, Oozeer R, Guyonnet D, Brazeilles R, Faurie JM, van Hylckama Vlieg JE, Houghton LA, Whorwell PJ, et al. Changes of the human gut microbiome induced by a fermented milk product. Sci Rep 2014;4:6328.
41. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011;94:3288-94.
42. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 2016; 133:187-225.
43. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006; 100:1171-85.
44. Norat T, Riboli E. Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr 2003;57:1-17.
45. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009;15: 1546-58.
46. Tapsell LC. Fermented dairy food and CVD risk. Br J Nutr 2015;113 (Suppl 2):S131-5.
47. Smith JD, Hou T, Ludwig DS, Rimm EB, Willett W, Hu FB, Mozaffarian D. Changes in intake of protein foods, carbohydrate amount and quality, and long-term weight change: results from 3 prospective cohorts. Am J Clin Nutr 2015;101:1216-24.
48. Wang H, Troy L, Rogers G, Fox C, McKeown N, Meigs J, Jacques P. Longitudinal association between dairy consumption and changes of body weight and waist circumference: the Framingham Heart Study. Int J Obes (Lond) 2014;38:299-305.
49. Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM, et al. Microbial reprogramming inhibits Western diet-associated obesity. PLoS One 2013;8:e68596.
50. Park D-Y, Ahn Y-T, Park S-H, Huh C-S, Yoo S-R, Yu R, Sung M-K, McGregor RA, Choi M-S. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 2013;8:e59470.
51. Power SE, O'Toole PW, Stanton C, Ross RP, Fitzgerald GF. Intestinal microbiota, diet and health. Br J Nutr 2014;111:387-402.
52. Walther B, Karl JP, Booth SL, Boyaval P. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr 2013;4:463-73.
53. Choi HJ, Yu J, Choi H, An JH, Kim SW, Park KS, Jang HC, Kim SY, Shin CS. Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care 2011;34:e147.
54. Melanson EL, Sharp TA, Schneider J, Donahoo WT, Grunwald GK, Hill JO. Relation between calcium intake and fat oxidation in adult humans. Int J Obes Relat Metab Disord 2003;27:196-203.
55. Zemel MB, Teegarden D, Van Loan M, Schoeller DA, Matkovic V, Lyle RM, Craig BA. Dairy-rich diets augment fat loss on an energyrestricted diet: a multicenter trial. Nutrients 2009;1:83-100.
56. Zemel MB. Role of dietary calcium and dairy products in modulating adiposity. Lipids 2003;38:139-46.
57. Ebel B, Lemetais G, Beney L, Cachon R, Sokol H, Langella P, Gervais P. Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr 2014;54:175-89.
58. Butel MJ. Probiotics, gut microbiota and health. Med Mal Infect 2014; 44:1-8.
59. DiBaise JK, Frank DN, Mathur R. Impact of the gut microbiota on the development of obesity: current concepts. Am J Gastroenterol Suppl 2012;1:22-7.
60. Pei R, Martin DA, DiMarco DM, Bolling BW. Evidence for the effects of yogurt on gut health and obesity. Crit Rev Food Sci Nutr 2017;57: 1569-83.
61. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obes Rev 2007;8:109-18.
62. Zemel MB. The role of dairy foods in weight management. J Am Coll Nutr 2005; 24(Suppl):537S-46S.
63. Zemel MB, ThompsonW, Milstead A, Morris K, Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 2004;12:582-90.
64. Kallus SJ, Brandt LJ. The intestinal microbiota and obesity. J Clin Gastroenterol 2012;46:16-24.
65. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
66. Tsuchiya A, Almiron-Roig E, Lluch A, Guyonnet D, Drewnowski A. Higher satiety ratings following yogurt consumption relative to fruit drink or dairy fruit drink. J Am Diet Assoc 2006;106:550-7.
67. Chapelot D, Payen F. Comparison of the effects of a liquid yogurt and chocolate bars on satiety: a multidimensional approach. Br J Nutr 2010;103:760-7.
68. Almiron-Roig E, Grathwohl D, Green H, Erkner A. Impact of some isoenergetic snacks on satiety and next meal intake in healthy adults. J Hum Nutr Diet 2009;22:469-74.
69. Salas-Salvadó J, Guasch-Ferré M, Diaz-López A, Babio N. Yogurt and diabetes: overview of recent observational studies. J Nutr 2017;147: 1452S-61S.
70. Rautiainen S, Wang L, Lee IM, Manson JE, Buring JE, Sesso HD. Dairy consumption in association with weight change and risk of becoming overweight or obese in middle-aged and older women: a prospective cohort study. Am J Clin Nutr 2016;103:979-88.
71. Crichton GE, Alkerwi A. Whole-fat dairy food intake is inversely associated with obesity prevalence: findings from the Observation of Cardiovascular Risk Factors in Luxembourg study. Nutr Res 2014; 34:936-43.
72. Vergnaud AC, Peneau S, Chat-Yung S, Kesse E, Czernichow S, Galan P, Hercberg S, Bertrais S. Dairy consumption and 6-y changes in body weight and waist circumference in middle-aged French adults. Am J Clin Nutr 2008;88:1248-55.
73. Samara A, Herbeth B, Ndiaye NC, Fumeron F, Billod S, Siest G, Visvikis-Siest S. Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study. Nutrition 2013;29:519-24.
74. Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B, Skeie G, Olsen A, Tjonneland A, Dahm CC, Overvad K, et al. Consumption of dairy products and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS One 2013;8:e72715.
75. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012;96:735-47.
76. Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 2013;52:1-24.
77. Veldhorst M, Smeets A, Soenen S, Hochstenbach-Waelen A, Hursel R, Diepvens K, Lejeune M, Luscombe-Marsh N, Westerterp-Plantenga M. Protein-induced satiety: effects and mechanisms of different proteins. Physiol Behav 2008;94:300-7.
78. Astrup A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies. Am J Clin Nutr 2014; 99(Suppl):1235S-42S.
79. El-Abbadi NH, Dao MC, Meydani SN. Yogurt: role in healthy and active aging. Am J Clin Nutr 2014; 99(Suppl):1263S-70S.
80. Martini LA, Catania AS, Ferreira SR. Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr Rev 2010;68:341-54.
81. Sluijs I, Forouhi NG, Beulens JW, van der Schouw YT, Agnoli C, Arriola L, Balkau B, Barricarte A, Boeing H, Bueno-de-Mesquita HB, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct study. Am J Clin Nutr 2012;96:382-90.
82. Ericson U, Hellstrand S, Brunkwall L, Schulz CA, Sonestedt E, Wallstrom P, Gullberg B, Wirfalt E, Orho-Melander M. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr 2015;101: 1065-80.
83. Nestel PJ, Mellett N, Pally S, Wong G, Barlow CK, Croft K, Mori TA, Meikle PJ. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br J Nutr 2013;110:2242-9.
84. Caricilli AM, Saad MJA. The role of gut microbiota on insulin resistance. Nutrients 2013;5:829-51.
85. Drehmer M, Pereira MA, Schmidt MI, Molina MDB, Alvim S, Lotufo PA, Duncan BB. Associations of dairy intake with glycemia and insulinemia, independent of obesity, in Brazilian adults: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Am J Clin Nutr 2015;101:775-82.
86. Ruan Y, Sun J, He J, Chen F, Chen R, Chen H. Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials. PLoS One 2015;10:e0132121.
87. Sun J, Buys N. Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials. Ann Med 2015;47:430-40.
88. Thorning TK, Bertram HC, Bonjour JP, de Groot L, Dupont D, Feeney E, Ipsen R, Lecerf JM, Mackie A, McKinley MC, et al. Whole dairy matrix or single nutrients in assessment of health effects: current evidence and knowledge gaps. Am J Clin Nutr 2017;105:1033-45.
89. Marette A, Picard-Deland E. Yogurt consumption and impact on health: focus on children and cardiometabolic risk. Am J Clin Nutr 2014;99:1243S-7S.
90. Lecerf J-M, Legrand P. Les effets des nutriments dépendent-ilsdes aliments qui les portent ? L'effet matrice. Cahiers de nutrition et de diététique 2015;50:158-64.
91. Jacobs DR Jr., Gross MD, Tapsell LC. Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr 2009;89:1543S-8S.
92. Mohammadi R, Sohrabvandi S, Mortazavian AM. The starter culture characteristics of probiotic microorganisms in fermented milks. Eng Life Sci 2012;12:399-409.
93. Lamothe S, Azimy N, Bazinet L, Couillard C, Britten M. Interaction of green tea polyphenols with dairy matrices in a simulated gastrointestinal environment. Food Funct 2014;5:2621-31.
94. Turgeon SL, Rioux L-E. Food matrix impact on macronutrients nutritional properties. Food Hydrocoll 2011;25:1915-24.
95. Barbé F, Ménard O, Le Gouar Y, Buffière C, Famelart M-H, Laroche B, Le Feunteun S, Dupont D, Rémond D. The heat treatment and the gelation are strong determinants of the kinetics of milk proteins digestion and of the peripheral availability of amino acids. Food Chem 2013;136:1203-12.
96. Le Feunteun S, Barbe F, Remond D, Menard O, Le Gouar Y, Dupont D, Laroche B. Impact of the dairy matrix structure on milk protein digestion kinetics: mechanistic modelling based on mini-pig in vivo data. Food Bioprocess Technol 2014;7:1099-113.
97. Fernández M, Hudson JA, Korpela R, de los Reyes-Gavilán CG. Impact on human health of microorganisms present in fermented dairy products: an overview. Biomed Res Int 2015;2015:412714.
98. Korhonen H. Milk-derived bioactive peptides: from science to applications. J Funct Foods 2009;1:177-87.
99. Frias J, Martinez-Villaluenga C, Penas E, editors. Fermented foods in health and disease prevention. London: Elsevier; 2016.
100. Jin Y, Yu Y, Qi Y, Wang F, Yan J, Zou H. Peptide profiling and the bioactivity character of yogurt in the simulated gastrointestinal digestion. J Proteomics 2016;141:24-46.
101. Chen G-W, Tsai J-S, Sun Pan B. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation. Int Dairy J 2007;17: 641-7.
102. Sabeena Farvin KH, Baron CP, Nielsen NS, Otte J, Jacobsen C. Antioxidant activity of yoghurt peptides: part 2-characterisation of peptide fractions. Food Chem 2010;123:1090-7.
103. Plaisancié P, Boutrou R, Estienne M, Henry G, Jardin J, Paquet A, Léonil J. Beta-Casein(94-123)-derived peptides differently modulate production of mucins in intestinal goblet cells. J Dairy Res 2015;82: 36-46.
104. Plaisancié P, Claustre J, Estienne M, Henry G, Boutrou R, Paquet A, Léonil J. A novel bioactive peptide from yoghurts modulates expression of the gel-forming MUC2 mucin as well as population of goblet cells and Paneth cells along the small intestine. J Nutr Biochem 2013; 24:213-21.
105. Zingone F, Bucci C, Iovino P, Ciacci C. Consumption of milk and dairy products: facts and figures. Nutrition 2017;33:322-5.
106. Shantha NC, Ram LN, O'Leary J, Hicks CL, Decker EA. Conjugated linoleic acid concentrations in dairy products as affected by processing and storage. J Food Sci 1995;60:695-8.
107. Aneja RP, Murthi TN. Conjugated linoleic acid contents of Indian curd and ghee. Indian J Dairy Sci 1990;43:231-8.
108. Oliveira RPS, Florence ACR, Silva RC, Perego P, Converti A, Gioielli LA, Oliveira MN. Effect of different prebiotics on the fermentation kinetics, probiotic survival and fatty acids profiles in nonfat symbiotic fermented milk. Int J Food Microbiol 2009;128:467-72.
109. Sosa-Castañeda J, Hernández-Mendoza A, Astiazarán-García H, Garcia HS, Estrada-Montoya MC, Gonzalez-Córdova AF, Vallejo-Cordoba B. Screening of Lactobacillus strains for their ability to produce conjugated linoleic acid in milk and to adhere to the intestinal tract. J Dairy Sci 2015;98:6651-9.
110. Allen LH. Calcium bioavailability and absorption: a review. Am J Clin Nutr 1982;35:783-808.
111. Zivkovic AM, Barile D. Bovine milk as a source of functional oligosaccharides for improving human health. Adv Nutr 2011;2:284-9.
112. Lamoureux L, Roy D, Gauthier SF. Production of oligosaccharides in yogurt containing bifidobacteria and yogurt cultures. J Dairy Sci 2002; 85:1058-69.
113. Hill D, Sugrue I, Arendt E, Hill C, Stanton C, Ross RP. Recent advances in microbial fermentation for dairy and health. F1000Res 2017; 6:751.
114. Anhê FF, Varin TV, Le Barz M, Desjardins Y, Levy E, Roy D, Marette A. Gut microbiota dysbiosis in obesity-linked metabolic diseases and prebiotic potential of polyphenol-rich extracts. Curr Obes Rep 2015;4: 389-400.
115. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012;148: 1258-70.
116. Shen J, Obin MS, Zhao LP. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 2013;34:39-58.
117. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 2013;27:73-83.
118. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11: 506-14.
119. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the substantiation of health claims related to live yogurt cultures and improved lactose digestion. EFSA J 2010;8:1763.
120. Canadian Food Inspection Agency. Probiotic claims [Internet]. 2016 [cited 2016 Aug 15]. Available from: http://www.inspection.gc.ca/food/labelling/food-labelling-for-industry/health-claims/eng/1392834838383/1392834887794?chap=9#s21c9.
121. Rijkers GT, de Vos WM, Brummer RJ, Morelli L, Corthier G, Marteau P. Health benefits and health claims of probiotics: bridging science and marketing. Br J Nutr 2011;106:1291-6.
122. Azaïs-Braesco V, Bresson JL, Guarner F, Corthier G. Not all lactic acid bacteria are probiotics, .but some are. Br J Nutr 2010;103:1079-81.
123. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002;109:678-84.
124. Scourboutakos M, Franco-Arellano B, Murphy S, Norsen S, Comelli E, L'Abbé M. Mismatch between probiotic benefits in trials versus food products. Nutrients 2017;9:400.
125. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012;28:539-43.
126. Mohamadshahi M, Veissi M, Haidari F, Javid AZ, Mohammadi F, Shirbeigi E. Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: a randomized controlled clinical trial. J Res Med Sci 2014;19:531-6.
127. Gibson PR, Muir JG. Reinforcing the mucus: a new therapeutic approach for ulcerative colitis? Gut 2005;54:900-3.
128. Derrien M, van Hylckama Vlieg JE. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol 2015;23:354-66.
129. Shah NP, editor. Yogurt in health and disease prevention. London: Elsevier; 2017.
130. Putt KK, Pei R, White HM, Bolling BW. Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions. Food Funct 2017;8:406-14.
131. Martini MC, Lerebours EC, Lin WJ, Harlander SK, Berrada NM, Antoine JM, Savaiano DA. Strains and species of lactic acid bacteria in fermented milks (yogurts): effect on in vivo lactose digestion. Am J Clin Nutr 1991;54:1041-6.
132. Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904.
133. Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E, Ngom-Bru C, Berger B, Philippe L, Ammon-Zuffrey C, et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 2014;111:1507-19.
134. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012;7:91-109.
135. Chandan RC, Kilara A, editors. Manufacturing yogurt and fermented milks. Hoboken (NJ): Wiley-Blackwell; 2013.
136. Panahi S, Tremblay A. The potential role of yogurt in weight management and prevention of type 2 diabetes. J Am Coll Nutr 2016;35: 717-31.
137. Dougkas A, Minihane AM, Givens DI, Reynolds CK, Yaqoob P. Differential effects of dairy snacks on appetite, but not overall energy intake. Br J Nutr 2012;108:2274-85.
138. Akhavan T, Luhovyy BL, Brown PH, Cho CE, Anderson GH. Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am J Clin Nutr 2010;91:966-75.
139. Akhavan T, Luhovyy BL, Panahi S, Kubant R, Brown PH, Anderson GH. Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults. J Nutr Biochem 2014;25:36-43.
140. Anderson GH, Tecimer SN, Shah D, Zafar TA. Protein source, quantity, and time of consumption determine the effect of proteins on short-term food intake in young men. J Nutr 2004;134:3011-5.
141. Boirie Y, Dangin M, Gachon P, Vasson MP, Maubois JL, Beaufrere B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci USA 1997;94:14930-5.
142. Chungchunlam SM, Henare SJ, Ganesh S, Moughan PJ. Dietary whey protein influences plasma satiety-related hormones and plasma amino acids in normal-weight adult women. Eur J Clin Nutr 2015; 69:179-86.
143. El Khoury D, Brown P, Smith G, Berengut S, Panahi S, Kubant R, Anderson GH. Increasing the protein to carbohydrate ratio in yogurts consumed as a snack reduces post-consumption glycemia independent of insulin. Clin Nutr 2014;33:29-38.
144. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003;89:239-48.
145. Nongonierma AB, FitzGerald RJ. Bioactive properties of milk proteins in humans: a review. Peptides 2015;73:20-34.
146. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A, Westerterp KR, Engelen MP, Brummer RJ, Deutz NE, Westerterp-Plantenga MS. A breakfast with alpha-lactalbumin, gelatin, or gelatin + TRP lowers energy intake at lunch compared with a breakfast with casein, soy, whey, or whey-GMP. Clin Nutr 2009;28:147-55.
147. Mortensen LS, Holmer-Jensen J, Hartvigsen ML, Jensen VK, Astrup A, de Vrese M, Holst JJ, Thomsen C, Hermansen K. Effects of different fractions of whey protein on postprandial lipid and hormone responses in type 2 diabetes. Eur J Clin Nutr 2012;66:799-805.
148. Ma J, Jesudason DR, Stevens JE, Keogh JB, Jones KL, Clifton PM, Horowitz M, Rayner CK. Sustained effects of a protein 'preload' on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract 2015;108: e31-4.
149. Nagpal R, Behare P, Rana R, Kumar A, Kumar M, Arora S, Morotta F, Jain S, Yadav H. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food Funct 2011;2:18-27.
150. Rai AK, Sanjukta S, Jeyaram K. Production of angiotensin i converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension. Crit Rev Food Sci Nutr 2017; 57:2789-800.
151. Fekete áA, Givens DI, Lovegrove JA. Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials. Nutrients 2015;7:659-81.
152. Steffen LM, Kroenke CH, Yu X, Pereira MA, Slattery ML, Van Horn L, Gross MD, Jacobs DR Jr. Associations of plant food, dairy product, and meat intakes with 15-y incidence of elevated blood pressure in young black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 2005;82:1169-77; quiz 1363-4.
153. Beydoun MA, Gary TL, Caballero BH, Lawrence RS, Cheskin LJ, Wang Y. Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 2008;87:1914-25.
154. Song JJ, Wang Q, Du M, Li TG, Chen B, Mao XY. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling. Mol Nutr Food Res 2017;61: 1600301.
155. Xu SP, Mao XY, Cheng X, Chen B. Ameliorating effects of casein glycomacropeptide on obesity induced by high-fat diet in male Sprague-Dawley rats. Food Chem Toxicol 2013;56:1-7.
156. Keogh JB, Clifton P. The effect of meal replacements high in glycomacropeptide on weight loss and markers of cardiovascular disease risk. Am J Clin Nutr 2008;87:1602-5.
157. Sawin EA, De Wolfe TJ, Aktas B, Stroup BM, Murali SG, Steele JL, Ney DM. Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. Am J Physiol Gastrointest Liver Physiol 2015;309: G590-601.
158. Boylston TD, Beitz DC. Conjugated linoleic acid and fatty acid composition of yogurt produced from milk of cows fed soy oil and conjugated linoleic acid. J Food Sci 2002;67:1973-8.
159. Nagao K, Yanagita T. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res 2010;61:208-12.
160. Marten B, Pfeuffer M, Schrezenmeir J. Medium-chain triglycerides. Int Dairy J 2006;16:1374-82.
161. Lemarié F, Beauchamp E, Legrand P, Rioux V. Revisiting the metabolism and physiological functions of caprylic acid (C8:0) with special focus on ghrelin octanoylation. Biochimie 2016;120:40-8.
162. Babayan VK. Medium chain triglycerides and structured lipids. Lipids 1987;22:417-20.
163. Schönfeld P, Wojtczak L. Short-and medium-chain fatty acids in energy metabolism: the cellular perspective. J Lipid Res 2016;57:943-54.
164. Bueno NB, de Melo IV, Florencio TT, Sawaya AL. Dietary mediumchain triacylglycerols versus long-chain triacylglycerols for body composition in adults: systematic review and meta-analysis of randomized controlled trials. J Am Coll Nutr 2015;34:175-83.
165. Mumme K, Stonehouse W. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J Acad Nutr Diet 2015;115:249-63.
166. Haug A, Hostmark AT, Harstad OM. Bovine milk in human nutrition-a review. Lipids Health Dis 2007;6:25.
167. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146-55.
168. Wein S, WolfframS, Schrezenmeir J, Gasperikova D, Klimes I, Sebokova E. Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats. Diabetes Metab Res Rev 2009;25:185-94.
169. Takeuchi H, Noguchi O, Sekine S, Kobayashi A, Aoyama T. Lower weight gain and higher expression and blood levels of adiponectin in rats fed medium-chain tag compared with long-chain tag. Lipids 2006;41:207-12.
170. Turner N, Hariharan K, TidAng J, Frangioudakis G, Beale SM, Wright LE, Zeng XY, Leslie SJ, Li JY, Kraegen EW, et al. Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes 2009;58:2547-54.
171. Eckel RH, Hanson AS, Chen AY, Berman JN, Yost TJ, Brass EP. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes 1992;41:641-7.
172. Han JR, Deng B, Sun J, Chen CG, Corkey BE, Kirkland JL, Ma J, Guo W. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism 2007;56: 985-91.
173. Nagao K, Yanagita T. Bioactive lipids in metabolic syndrome. Prog Lipid Res 2008;47:127-46.
174. Parodi PW. Cooperative action of bioactive components in milk fat with PPARs may explain its anti-diabetogenic properties. Med Hypotheses 2016;89:1-7.
175. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997; 32:853-8.
176. Sisk MB, Hausman DB, Martin RJ, Azain MJ. Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J Nutr 2001;131:1668-74.
177. Takahashi Y, Kushiro M, Shinohara K, Ide T. Dietary conjugated linoleic acid reduces body fat mass and affects gene expression of proteins regulating energy metabolism in mice. Comp Biochem Physiol B Biochem Mol Biol 2002;133:395-404.
178. Ryder JW, Portocarrero CP, Song XM, Cui L, Yu M, Combatsiaris T, Galuska D, Bauman DE, Barbano DM, Charron MJ, et al. Isomerspecific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001;50:1149-57.
179. Houseknecht KL, Heuvel JPV, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, Belury MA. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998;244:678-82.
180. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 2002;22: 505-31.
181. Wang Y, Jacome-Sosa MM, Ruth MR, Lu Y, Shen J, Reaney MJ, Scott SL, Dugan ME, Anderson HD, Field CJ, et al. The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-alpha and-gamma in a rodent model of dyslipidemia and the metabolic syndrome. Mol Nutr Food Res 2012;56:1234-46.
182. Barberá MJ, Schlüter A, Pedraza N, Iglesias R, Villarroya F, Giralt M. Peroxisome proliferator-activated receptor a activates transcription of the brown fat uncoupling protein-1 gene: a link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell. J Biol Chem 2001;276:1486-93.
183. Stanford KI, Middelbeek RJW, Townsend KL, An D, Nygaard EB, Hitchcox KM, Markan KR, Nakano K, Hirshman MF, Tseng Y-H, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 2013;123:215-23.
184. Kim SH, Plutzky J. Brown fat and browning for the treatment of obesity and related metabolic disorders. Diabetes Metab J 2016;40: 12-21.
185. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009;58:1509-17.
186. Tremblay A, Gilbert JA. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009;28(Suppl 1):91S-102S.
187. Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem 1998;188:129-36.
188. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S. Calcium intake and body weight. J Clin Endocrinol Metab 2000;85:4635-8.
189. Pittas AG, Lau J, Hu F, Dawson-Hughes B. Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 2007;92:2017-29.
190. Gedik O, Zileli MS. Effects of hypocalcemia and theophylline on glucose tolerance and insulin release in human beings. Diabetes 1977; 26:813-9.
191. Yasuda K, Hurukawa Y, Okuyama M, Kikuchi M, Yoshinaga K. Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release. N Engl J Med 1975;292:501-4.
192. Beaulieu C, Kestekian R, Havrankova J, Gascon-Barre M. Calcium is essential in normalizing intolerance to glucose that accompanies vitamin d depletion in vivo. Diabetes 1993;42:35-43.
193. Hochberg Z, Borochowitz Z, Benderli A, Vardi P, Oren S, Spirer Z, Heyman I, Weisman Y. Does 1, 25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands? J Clin Endocrinol Metab 1985;60:57-61.
194. Wright DC, Hucker KA, Holloszy JO, Han DH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 2004;53:330-5.
195. Draznin B, Sussman K, Kao M, Lewis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 1987;262:14385-8.
196. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Otsuka K, Saruta T. Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens 1993;11:421-6.
197. Weaver C, Heaney RP, editors. Calcium in human health. Totowa (NJ): Humana Press; 2006.
198. Gopinath B, Flood VM, Burlutsky G, Louie JC, Baur LA, Mitchell P. Dairy food consumption, blood pressure and retinal microcirculation in adolescents. Nutr Metab Cardiovasc Dis 2014;24:1221-7.
199. Wang H, Fox CS, Troy LM, McKeown NM, Jacques PF. Longitudinal association of dairy consumption with the changes in blood pressure and the risk of incident hypertension: the Framingham Heart Study. Br J Nutr 2015;114:1887-99.
200. Zemel MB. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 2001;20(Suppl):428S-35S; discussion 40S-2S.
201. Wang L, Manson JE, Sesso HD. Calcium intake and risk of cardiovascular disease a review of prospective studies and randomized clinical trials. Am J Cardiovasc Drugs 2012;12:105-16.
202. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344: 3-10.
203. Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin P-H, Caccia C, Johnson J, Waugh R, Sherwood A. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 2010; 170:126-35.
204. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 2002;21:146S-51S.
205. Cormick G, Ciapponi A, Cafferata ML, Belizan JM. Calcium supplementation for prevention of primary hypertension. Cochrane Database Syst Rev 2015;(6):CD010037.
206. Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Educ 2003;27:201-6.
207. Belizán JM, Villar J, Repke J. The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. Am J Obstet Gynecol 1988;158:898-902.
208. Zhang YH. Neuronal nitric oxide synthase in hypertension-an update. Clin Hypertens 2016;22:20.
209. Tremblay A, Gilbert JA. Human obesity: is insufficient calcium/dairy intake part of the problem? J Am Coll Nutr 2011; 30(Suppl 1):449S-53S.
210. Major GC, Chaput JP, Ledoux M, St-Pierre S, Anderson GH, Zemel MB, Tremblay A. Recent developments in calcium-related obesity research. Obes Rev 2008;9:428-45.
211. Melanson EL, Donahoo WT, Dong F, Ida T, Zemel MB. Effect of lowand high-calcium dairy-based diets on macronutrient oxidation in humans. Obes Res 2005;13:2102-12.
212. Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH, Tremblay A, Astrup A. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 2009;10:475-86.
213. Hackam DG. Translating animal research into clinical benefit. BMJ 2007;334:163-4.
214. Tremblay F, Lavigne C, Jacques H, Marette A. Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of highfat-fed obese rats. Diabetes 2003;52:29-37.
215. Johnson MS, Jumbo-Lucioni P, Watts AJ, Allison DB, Nagy TR. Effect of dairy supplementation on body composition and insulin resistance in mice. Nutrition 2007;23:836-43.
216. Chang BJ, Park SU, Jang YS, Ko SH, Joo NM, Kim SI, Kim CH, Chang DK. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur J Clin Nutr 2011;65:1250-5.
217. Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A. The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies. Eur J Clin Nutr 2000;54:856-60.
218. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A, Heravifard S, Tayebinejad N, et al. Daily consumption of vitamin D-or vitamin D + calciumfortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011; 93:764-71.
219. Adolfsson O, Meydani SN, Russell RM. Yogurt and gut function. Am J Clin Nutr 2004;80:245-56.